...
search icon
bioa-img

BioAge Labs, Inc Share Price

BIOA
NSQ
$19.59
-$0.04
(-0.2%)
1D
Industry: Pharmaceuticals Sector: Health Care

BioAge Labs, Inc Analyst Forecast

BioAge Labs, Inc Share Price Chart

BioAge Labs, Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$819.60M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
1.4423
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.12M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.88 L
$24 H
$19.59

About BioAge Labs, Inc, Common Stock

BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. It also provides azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California. more

Industry: PharmaceuticalsSector: Health Care

BioAge Labs, Inc Stock Returns

Time FrameBIOASectorS&P500
1-Week Return-1.8%0.72%-1.31%
1-Month Return-7.93%1.27%0.78%
3-Month Return137.94%3.13%3.46%
6-Month Return334.29%15.81%6.19%
1-Year Return348.17%8.89%11.68%
3-Year Return7.21%20.79%71.21%

BioAge Labs, Inc Financials

Dec '16Dec '17Dec '22Dec '23Dec '245YR TREND
Total Revenue8.27M14.94M---[{"date":"2016-12-31","value":55.36,"profit":true},{"date":"2017-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue13.67M22.32M---[{"date":"2016-12-31","value":61.22,"profit":true},{"date":"2017-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(5.39M)(7.38M)---[{"date":"2016-12-31","value":-539444000,"profit":false},{"date":"2017-12-31","value":-738049600,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin(65.21%)(49.39%)---[{"date":"2016-12-31","value":-65.21,"profit":false},{"date":"2017-12-31","value":-49.39,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses24.24M102.63M39.97M48.40M78.19M[{"date":"2016-12-31","value":23.61,"profit":true},{"date":"2017-12-31","value":100,"profit":true},{"date":"2022-12-31","value":38.94,"profit":true},{"date":"2023-12-31","value":47.16,"profit":true},{"date":"2024-12-31","value":76.19,"profit":true}]
Operating Income(29.63M)(110.01M)(39.97M)(48.40M)(78.19M)[{"date":"2016-12-31","value":-2962997000,"profit":false},{"date":"2017-12-31","value":-11001330400,"profit":false},{"date":"2022-12-31","value":-3996900000,"profit":false},{"date":"2023-12-31","value":-4840000000,"profit":false},{"date":"2024-12-31","value":-7819400000,"profit":false}]
Total Non-Operating Income/Expense--471.00K(20.82M)14.35M[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2022-12-31","value":3.28,"profit":true},{"date":"2023-12-31","value":-145.1,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(28.35M)(102.11M)(39.72M)(63.85M)(71.11M)[{"date":"2016-12-31","value":-2834504500,"profit":false},{"date":"2017-12-31","value":-10210504100,"profit":false},{"date":"2022-12-31","value":-3972200000,"profit":false},{"date":"2023-12-31","value":-6385400000,"profit":false},{"date":"2024-12-31","value":-7110900000,"profit":false}]
Income Taxes25.65K81.73K241.00K7.79M(71.11M)[{"date":"2016-12-31","value":0.33,"profit":true},{"date":"2017-12-31","value":1.05,"profit":true},{"date":"2022-12-31","value":3.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-912.36,"profit":false}]
Income After Taxes--(39.96M)(71.65M)-[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations--(39.72M)(63.85M)(71.11M)[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-3972200000,"profit":false},{"date":"2023-12-31","value":-6385400000,"profit":false},{"date":"2024-12-31","value":-7110900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(22.48M)(98.15M)(39.72M)(63.85M)(71.11M)[{"date":"2016-12-31","value":-2247808100,"profit":false},{"date":"2017-12-31","value":-9815147300,"profit":false},{"date":"2022-12-31","value":-3972200000,"profit":false},{"date":"2023-12-31","value":-6385400000,"profit":false},{"date":"2024-12-31","value":-7110900000,"profit":false}]
EPS (Diluted)----(8.30)[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-830,"profit":false}]

BioAge Labs, Inc Ratios

BioAge Labs, Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

BIOA
Cash Ratio 11.67
Current Ratio 11.87

BioAge Labs, Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BIOA
ROA (LTM) -17.46%
ROE (LTM) -25.64%

BioAge Labs, Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BIOA
Debt Ratio Lower is generally better. Negative is bad. 0.09
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.91

BioAge Labs, Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BIOA
Trailing PE 1.44
Forward PE NM
P/S (TTM) 138.52
P/B 2.94
Price/FCF NM
EV/R 91.00
EV/Ebitda NM

FAQs

What is BioAge Labs, Inc share price today?

BioAge Labs, Inc (BIOA) share price today is $19.59

Can Indians buy BioAge Labs, Inc shares?

Yes, Indians can buy shares of BioAge Labs, Inc (BIOA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BIOA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of BioAge Labs, Inc be purchased?

Yes, you can purchase fractional shares of BioAge Labs, Inc (BIOA) via the Vested app. You can start investing in BioAge Labs, Inc (BIOA) with a minimum investment of $1.

How to invest in BioAge Labs, Inc shares from India?

You can invest in shares of BioAge Labs, Inc (BIOA) via Vested in three simple steps:

  • Click on Sign Up or Invest in BIOA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in BioAge Labs, Inc shares
What is BioAge Labs, Inc 52-week high and low stock price?

The 52-week high price of BioAge Labs, Inc (BIOA) is $24. The 52-week low price of BioAge Labs, Inc (BIOA) is $2.88.

What is BioAge Labs, Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of BioAge Labs, Inc (BIOA) is 1.4423

What is BioAge Labs, Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of BioAge Labs, Inc (BIOA) is 2.94

What is BioAge Labs, Inc dividend yield?

The dividend yield of BioAge Labs, Inc (BIOA) is 0.00%

What is the Market Cap of BioAge Labs, Inc?

The market capitalization of BioAge Labs, Inc (BIOA) is $819.60M

What is BioAge Labs, Inc's stock symbol?

The stock symbol (or ticker) of BioAge Labs, Inc is BIOA

How Can Investors Use BioAge Labs, Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of BioAge Labs, Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether BioAge Labs, Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from BioAge Labs, Inc shares for Indian investors?

When investing in BioAge Labs, Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the BioAge Labs, Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare BioAge Labs, Inc share price with other stocks in the same sector?

Rather than merely checking the share price of BioAge Labs, Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that BioAge Labs, Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top